drugset / Trial / NCT07310797

Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion

NCT07310797

RandomizedParallel-groupOpen-labelTreatment

Summary

This randomized controlled trial compares the efficacy and safety of four treatment strategies for ureteral stone expulsion: Mirabegron alone, Tamsulosin alone, a combination of both, and standard conservative care. Participants diagnosed with ureteral stones will be randomly assigned to one of these four groups. The primary objective is to evaluate the stone expulsion rate within 4 weeks. The study also assesses time to expulsion, pain intensity, analgesic use, and potential side effects.

Timeline

Start
2026-02-13
Primary completion
2029-12-31
Completion
2030-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Mirabegron Other / unclassified 50 mg Oral
Subject Tamsulosin Other / unclassified 0.4 mg Oral

Indications